Matthew Kronick, MD
Vascular Surgery · Springfield, MANPI 1619233699
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $4,337 of the $6,314 with a category attached, or 68.7%. 12 manufacturers reported payments, led by Cook Medical LLC at 26.6% of the total. Reporting peaked in 2019 at $2,280 and has fallen 82.0% since, to $409 in 2025.
Across 72 payments — averaging $87.69 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Cook Medical LLC$2K
- Silk Road Medical, Inc.$1K
- Bolton Medical Inc$817
- Endologix LLC$572
- Abbott$545
- W. L. Gore & Associates, Inc.$401
- plus $968 from 6 others
Across 12 payments — averaging $5139.67 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Medtronic$62K
What the payments were for
- Speaking & faculty fees$5008%
- Grants$67611%
- Travel & lodging$80113%
- Food & beverage$4,33769%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Cook Medical LLC | 14 | $1,682 |
| Silk Road Medical, Inc. | 12 | $1,328 |
| Bolton Medical Inc | 4 | $817 |
| Endologix LLC | 8 | $572 |
| Abbott | 8 | $545 |
| W. L. Gore & Associates, Inc. | 7 | $401 |
| Medtronic(2 entities) | 7 | $390 |
| Boston Scientific | 3 | $185 |
| Veryan Medical Incorporated | 2 | $146 |
| Cagent Vascular Inc | 5 | $119 |
| Shockwave Medical, Inc | 1 | $113 |
| Pfizer | 1 | $16 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- ENROUTE Transcarotid Neuroprotection System$940
- ENROUTE Transcarotid Stent System$812
- ENHANCE Transcarotid Peripheral Access Kit$812
- ENROUTE 0.014 Guidewire$812
- Grafts$662
- ENROUTE Transcarotid Stent$249
- Relay Grafts$149
- ABSOLUTE PRO$137
- Zenith$135
- JETi All In One Non-Sterile Kit$125
- Cook Medical AAA$125
- BioMimics 3D Vascular Stent System$123
- GORE TAG Thoracic Endoprosthesis$120
- Cook Medical Zilver PTX$120
- Zenith Alpha$118
- ENDURANT IIS$117
- SUPERA$115
- ENDOCROSS Device$115
- Torus Stent Graft System$115
- Shockwave IVL System with the Shockwave C2 Coronary IVL Catheter$113
How this compares
$6,314 in reported general payments places this provider in the 60th percentile of 142 vascular surgery providers in Massachusetts.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 38 | $31,518 |
| XareltoRivaroxaban | 29 | $24,029 |
| ClopidogrelClopidogrel Bisulfate | 78 | $1,268 |
| Cilostazol | 63 | $1,136 |
| Atorvastatin Calcium | 48 | $711 |
| Gabapentin | 36 | $576 |
| Oxycodone Hcl | 26 | $330 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| PfizerEliquis | $16 | $31,51838 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 60th percentile of 142 vascular surgery providers in Massachusetts.
Other vascular surgery in Springfield
- Yiming ChingSpringfield$13K
- Hazel MareckiSpringfield$6K
- Thomas OdonnellBoston$845K
- Scott JamesPlymouth$199K
- Anahita DuaBoston$186K
- Dejah JudelsonWorcester$92K
- Jonathan GertlerWeston$90K
- Andres SchanzerWorcester$84K
- Richard PinNorth Dartmouth$73K
- Marc SchermerhornBoston$71K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.